TheraRadar
← Back
Data updated: Mar 29, 2026

AMNEAL PHARMS NY

CardiovascularGastroenterologyDermatology
Generics

AMNEAL PHARMS NY is a generic drug manufacturer focused on Cardiovascular, Gastroenterology, Dermatology.

1986
Since
30
Drugs
-
Trials
741
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

GABAPENTIN 2026-02-24
Labeling
GABAPENTIN 2026-02-18
Labeling
AMLODIPINE BESYLATE 2026-02-17
Manufacturing (CMC)
GABAPENTIN 2026-02-17
Labeling
GABAPENTIN 2026-02-17
Labeling
GABAPENTIN 2026-02-12
Labeling
SULFAMETHOXAZOLE AND TRIMETHOPRIM 2026-02-10
Labeling
ISOTRETINOIN 2026-02-09
REMS
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 29%
2 drugs
Gastroenterology 29%
2 drugs
Dermatology 14%
1 drugs
Immunology 14%
1 drugs
Infectious Disease 14%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Infectious Disease, Dermatology, Immunology, Gastroenterology
BAUSCH specialty
Dermatology, Immunology, Cardiovascular, Gastroenterology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Immunology
BAUSCH AND LOMB specialty
Cardiovascular, Infectious Disease, Dermatology, Immunology
APOTHECON specialty
Infectious Disease, Dermatology, Cardiovascular, Gastroenterology